Schechter MT - Search Results

1

Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.

Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, MacPhail IA, Puskaric J, Sadowski RP, Singer J, Schechter MT, Wood VM. Abu-Laban RB, et al. Among authors: schechter mt. N Engl J Med. 2002 May 16;346(20):1522-8. doi: 10.1056/NEJMoa012885. N Engl J Med. 2002. PMID: 12015391 Free article. Clinical Trial.

2

Spinal bone loss and ovulatory disturbances.

Prior JC, Vigna YM, Schechter MT, Burgess AE. Prior JC, et al. Among authors: schechter mt. N Engl J Med. 1990 Nov 1;323(18):1221-7. doi: 10.1056/NEJM199011013231801. N Engl J Med. 1990. PMID: 2215605 Free article.

3

Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in graves' disease.

Mohaseb K, Linder M, Rootman J, Wilkins GE, Schechter MT, Dolman PJ, Singer J. Mohaseb K, et al. Among authors: schechter mt. Orbit. 2008;27(6):419-25. doi: 10.1080/01676830802414566. Orbit. 2008. PMID: 19085296

4

Diacetylmorphine versus methadone for the treatment of opioid addiction.

Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Oviedo-Joekes E, et al. Among authors: schechter mt. N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635. N Engl J Med. 2009. PMID: 19692689 Free PMC article. Clinical Trial.

5

The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT. Oviedo-Joekes E, et al. Among authors: schechter mt. J Urban Health. 2008 Nov;85(6):812-25. doi: 10.1007/s11524-008-9312-9. Epub 2008 Aug 29. J Urban Health. 2008. PMID: 18758964 Free PMC article.

6

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH. Bansback N, et al. Among authors: schechter mt. Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28. Addiction. 2018. PMID: 29589873

7

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Miller CL, et al. Among authors: schechter mt. J Urban Health. 2002 Jun;79(2):257-65. doi: 10.1093/jurban/79.2.257. J Urban Health. 2002. PMID: 12023501 Free PMC article.

8

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: schechter mt. AIDS. 2002 Oct 18;16(15):2065-72. doi: 10.1097/00002030-200210180-00012. AIDS. 2002. PMID: 12370506

9

An external evaluation of a peer-run "unsanctioned" syringe exchange program.

Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: schechter mt. J Urban Health. 2003 Sep;80(3):455-64. doi: 10.1093/jurban/jtg052. J Urban Health. 2003. PMID: 12930883 Free PMC article.

10

Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.

Palepu A, Tyndall MW, Li K, Yip B, O'Shaughnessy MV, Schechter MT, Montaner JS, Hogg RS. Palepu A, et al. Among authors: schechter mt. J Urban Health. 2003 Dec;80(4):667-75. doi: 10.1093/jurban/jtg073. J Urban Health. 2003. PMID: 14709714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

349 results

Search Page